Search clinical trials for: Detergent

Total 667 results

Changi General Hospital

Unknown

Microbiological Evaluation of the Efficacy of Water to Clean Tracheostomy Inner Cannulas

Tracheostomy Complication

Singapore
Imperial College London
University of Edinburgh; Universidad de Granada

Recruiting

Examining the Benefit of Graduated Compression Stockings in the Prevention of vEnous Thromboembolism in Low-risk Surgical Patients (PETS)

Venous Thromboembolism

United Kingdom
Can Tho Stroke International Services Hospital

Recruiting

Tandem Occlusions After Emergent Stenting in Acute Ischemic Stroke (TOESIS)

Acute Stroke | Ischemic Stroke, Acute

Vietnam
University Hospitals Cleveland Medical Center

Recruiting

Reparel Knee Sleeve vs. TED Hose for Post-op Swelling, Pain and Range of Motion After Total Knee Replacement

Osteoarthritis Knees Both

United States
Can Tho Stroke International Services Hospital

Completed

Emergent Stenting In Acute Vertebrobasilar Occlusions (ESVO)

Acute Stroke | Ischemic Stroke, Acute | Vertebro Basilar Ischemia

Vietnam
Loyola University

Completed

Compression Stocking Use in Shoulder Arthroscopy in Beach Chair

Obesity | Shoulder Impingement

United States
Octapharma

Terminated

Safety and Efficacy Study to Compare Uniplas With Cryosupernatant Plasma in Thrombotic Thrombocytopenic Purpura (TTP)

Thrombotic Thrombocytopenic Purpura (TTP)

United States
Rutgers, The State University of New Jersey

Recruiting

Emergent Multi-Class Imitation Training (EMIT)

Autism Spectrum Disorder

United States
Christopher Barwacz

Completed

Periimplant Mucosa Dynamics Around Divergent and Concave Atlantis Abutment Transition Profiles

Esthetics, Dental | Dental Implant, Single-Tooth

United States
Universitaire Ziekenhuizen KU Leuven

Unknown

Pre-hospital and Intra-hospital Temporal Delays in Patients Requiring Emergent Trauma Craniotomy

Brain Injuries, Traumatic
Baxter Healthcare Corporation

Completed

Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Hemostasis in Subjects Undergoing Total Hip Replacement

Hip Replacement Surgery

Austria, Germany, Netherlands
St. Olavs Hospital
Norwegian University of Science and Technology

Withdrawn

Prophylactic Plasma Infusion Therapy for Congenital Thrombotic Thrombocytopenic Purpura

Purpura, Thrombotic Thrombocytopenic
Abiomed Inc.

Completed

Restore EF Observational Study

Coronary Artery Disease | Angina, Stable | Unstable Angina | NSTEMI - Non-ST Segment Elevation MI

United States
Currax Pharmaceuticals

Completed

Real-World Evidence on the Cardiovascular Safety of CONTRAVE® in the United States (U.S.) (HOA)

Obesity

United States
Stanford University

Recruiting

Low-Dose Naltrexone for the Treatment of Complex Regional Pain Syndrome (LDN-CRPS)

Complex Regional Pain Syndrome

United States
Cytocom, Inc.

Recruiting

Single-Blind Study of STAT-205 in Mild COVID-19

COVID-19

United States
Alcobra Ltd.

Terminated

The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD

Attention Deficit Hyperactivity Disorder (ADHD)

United States, Israel
University of Pennsylvania
Medical University of South Carolina; NYU Langone Health; National Institute... and other collaborators

Terminated

Commensal Oral Microbiota in Head and Neck Cancer (ARMOR)

Head and Neck Cancer | Oral Mucositis

United States
Kantonsspital Aarau

Recruiting

Validation of the VascuQoL-6 Questionnaire to Assess ePROM After Revascularization for Lower Limb Peripheral Arterial Disease in German-speaking Part of Switzerland (VascuQol6ValCH)

Peripheral Arterial Disease

Switzerland
Pharnext SA
Ascopharm Groupe Novasco

Completed

24-week Open-label Extension Study Evaluating PXT00864 Effect in Mild AD Patients Further to PLEODIAL-I Completion (PLEODIAL-II)

Alzheimer Disease

France
Alkermes, Inc.

Completed

ALK21-025: Vivitrol's Cost and Treatment Outcomes Registry (VICTORY)

Opioid Dependence

United States
Baxter Healthcare Corporation

Completed

Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery

Cardiopulmonary Bypass | Sternotomy | Cardiac Surgery Requiring Cardiopulmonary Bypass and Median Sternotomy

United States
Pharnext SA
Ascopharm Groupe Novasco

Completed

Pilot Study Assessing the Effects of PXT00864 in Patients With Mild Alzheimer Disease (AD) (PLEODIAL-I)

Alzheimer Disease

France
Orexigen Therapeutics, Inc

Completed

Method-of-Use Study Assessing the Effect of Naltrexone Sustained Release (SR)/ Bupropion SR on Body Weight and Cardiovascular Risk Factors in Overweight and Obese Subjects

Obesity | Overweight

United States
Oregon Health and Science University
Oregon State University; Oregon Department of Corrections; CODA Inc.; Bridgeway... and other collaborators

Completed

Reducing Overdose After Release From Incarceration (ROAR)

Overdose, Drug

United States
University of Florida
National Institutes of Health (NIH); Universite d'Etat d'Haiti

Completed

Improving Nighttime Access to Care and Treatment (Part 2) (INACT2)

Acute Respiratory Infection | Acute Febrile Illness | Acute Diarrhea

Haiti
Hospital Universitari de Bellvitge

Completed

Impact of the COVID-19 Pandemic on the Surgical Activity of Bellvitge University Hospital

Covid19 | Surgery--Complications | Nosocomial Infection

Spain
Mayo Clinic

Completed

Acamprosate Safe to Use in Individuals With Liver Disease.

Alcohol-related Liver Disease

United States
Medical University of South Carolina

Completed

Open Label Trial of Acamprosate in Bipolar Alcoholics

Alcohol Dependence | Bipolar Disorder

United States
Kaiser Permanente
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Completed

PRimary Care Opioid Use Disorders Treatment (PROUD) Trial (PROUD)

Opioid-use Disorder

United States
New York State Psychiatric Institute

Completed

Lorcaserin in Combination With XR-Naltrexone for Relapse Prevention in Opioid Use Disorder

Opioid-use Disorder

United States
Medical University of South Carolina
Columbia University; Mclean Hospital

Completed

Acamprosate in Alcoholics With Comorbid Anxiety or Depression

Alcohol Dependence | Generalized Anxiety Disorder | Major Depression | Social Anxiety Disorder

United States
State University of New York - Upstate Medical...
University at Buffalo

Completed

Neuropsychoanalytic Treatment of Failed Back Surgery Syndrome-Opioid Dependence

Pain
The Cleveland Clinic

Withdrawn

Can The Bridge Transition Opiate Use Disorder Patients in Stable Recovery From Buprenorphine to Naltrexone

Substance Use | Substance Use Disorders | Substance Abuse | Substance Dependence

United States
Pharnext S.C.A.
Premier Research Group plc; Eurofins Optimed; Synteract HCR (Syneos Health); Gr... and other collaborators

Active, not recruiting

Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A (PLEO-CMT-FU)

Charcot-Marie-Tooth Disease, Type IA

United States, Belgium, Canada, France, Netherlands, Spain, United Kingdom
Ahvaz Jundishapur University of Medical Sciences

Completed

The Effect of Soy Isoflavones on Non-alcoholic Fatty Liver Disease and the Level of FGF-21 and Fetuin A

NAFLD

Iran, Islamic Republic of
Baylor College of Medicine
National Parkinson Foundation

Withdrawn

Acamprosate for Treatment of Compulsive Behaviors and Craving in Parkinson's Disease

Parkinson's Disease

United States
University of Oklahoma
Forest Laboratories

Terminated

Study of Acamprosate in Driving Under the Influence (DUI) Court Participants

Alcohol Dependence

United States
Mayo Clinic
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Pharmacogenomics and Pharmacometabolomics of Acamprosate Treatment Outcome

Alcohol Use Disorder

United States
Indiana University

Completed

Acamprosate in Youth With Fragile X Syndrome

Fragile X Syndrome | Autism Spectrum Disorders

United States
Virginia Commonwealth University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Terminated

Study of Acamprosate to Prevent Alcohol Relapse in Criminal Justice Supervisees

Alcohol Dependence

United States
Brown University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

A Novel Pharmacotherapy for Alcoholism and Alcohol Liver Disease

Alcoholic Liver Disease | Alcoholism,

United States
Pfizer

Completed

Study To Examine Effect Of CP-866,087 On Consumption And Craving Of Alcohol In Alcohol Dependent Subjects.

Alcoholism

United States
Butler Hospital
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Active, not recruiting

A Targeted, Real-Time, Technology-Supported Intervention for Patients With Alcohol Use Disorder on Disulfiram (Wisepill+SMS)

Drinking, Alcohol

United States
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Acamprosate Treatment: Mechanisms of Action

Alcoholism

United States
Talaria, Inc
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Adaptive Goal-Directed Adherence Tracking and Enhancement (AGATE)

Alcohol Abuse

United States
Forest Laboratories
National Institute on Drug Abuse (NIDA)

Completed

Acamprosate Initiated During Alcohol Detoxification

Alcohol Use Disorder

United States
University of Bristol

Completed

Alcohol Detoxification in Primary Care Treatment (ADEPT) (ADEPT)

Alcoholism

United Kingdom
Agios Pharmaceuticals, Inc.

Completed

Food Effect Study of AG120 in Healthy Subjects

Healthy

United States
University of Wisconsin, Madison
National Institute on Drug Abuse (NIDA)

Completed

Intervention to Expand Opioid Use Disorder Treatment Pharmacotherapy Prescribers

Opioid-use Disorder

United States

Search clinical trials for: Detergent

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo, DR of

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations